Parallel Expands into Illinois Cannabis Market with Agreement to Acquire Windy City
Transaction extends Parallel s strategic footprint to six states, concentrated in highly populated, limited license markets throughout the U.S.
News provided by
Share this article
Share this article
ATLANTA and WEST PALM BEACH, Fla., April 1, 2021 /PRNewswire/ Parallel, one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced it has entered into a definitive agreement to acquire, in a cash and stock transaction, certain operations of Windy City Cannabis, comprised of Posen Dispensary Holding Company, LLC, Homewood Holding Company, LLC, Homewood 2
nd Site Holding Company, LLC, Posen 2
MSO Parallel Enters Illinois Cannabis Market with $100 Million Acquisition – New Cannabis Ventures
newcannabisventures.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newcannabisventures.com Daily Mail and Mail on Sunday newspapers.
Parallel Expands into Illinois Cannabis Market with Agreement to Acquire Windy City
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Horizons ETFs Made Waves When They Launched the World’s First Psychedelics Stock ETF on the NEO Exchange Early This Year
The Dales Report sat down with Steve Hawkins, the President and CEO of Horizons ETFs for an interview, to learn a little bit more about the behind-the-scenes on creating a Psychedelics ETF like
Horizons Psychedelic Stock Index ETF (NEO: PSYK) from scratch, what investors should know, and where the Psychedelics industry – and others – might be headed. Right now, Hawkings says, the psychedelics industry resembles Cannabis in capital market structure. There’s very few companies in the space, but with big IPOs, and multiple U.S. companies that are looking at moving into Canadian space.
Poseidon Asset Management co-founder and managing director Morgan Paxhia recently spoke with Benzinga about some of the top low-cost buys on the market today, including several options investors could get for well under $100 per share.
Those with limited funds to invest might want to avoid a single shot stock, he advised. Those looking for beta exposure in the U.S. market, however, may want to consider
AdvisorShares Pure U.S. Cannabis ETF (NYSE:MSOS) to offset some risk with a diversified investment. I think it s just good financial sense, Paxhia, an investor since the age of 12, says.
Poseidon is one-half of one of the cannabis space s longest-running investment funds. Paxhia co-runs the firm with his sister, Emily. They have invested in some of market s top names, including